期刊文献+

Livin shRNA质粒载体的构建及评价

Construction and Evaluation of Recombinant Plasmid of Livin shRNA
原文传递
导出
摘要 目的:构建有效的Livin shRNA重组质粒。方法:设计、合成Livin shRNA,与pGenesil-1质粒载体链接构建重组质粒,通过酶切电泳、基因测序证实是否正确构建,通过转染高表达Livin的大肠癌HT-29细胞检测Livin mRNA下降水平,筛选出最佳的shRNA。结果:重组质粒pGenesil-shRNA经酶切电泳、基因测序证明寡核苷酸片段成功插入预计位点,且序列与我们设计合成的完全一致;重组质粒载体转染HT-29细胞后,肿瘤细胞Livin mRNA含量较转染前及对照组均有明显的下降(p<0.01),其中尤以Livin1抑制作用明显,抑制率达到66%。结论:我们正确构建了Livin ShRNA重组质粒,且制备的shRNA能有效抑制Livin基因的表达,为探讨针对Livin基因的RNAi对肿瘤的治疗奠实验基础。 Objective:To construct an effective recombinant plasmid of Livin shRNA. Methods:Livin shRNA was designed and synthetized,then linked with pGenesil-1 plasmid vector to construct a recombinant plasmid. At last we verified that the correct plasmid vector has been constructed by enzyme-cutting electro-phpresis and gene sequencing.The plasmid was transfected into HT-29 cell which express highly of Livin and the mRNA was detected to select the optmal shRNA. Results:Oligonucleotides were correctly inserted into the recombinant plasmid pGenesil-shRNA by enzyme-cutting electro-phoresis and gene sequencing and the sequence was completely the same as designed.After the recombinant plasmid vector was transfected into HT-29 cell,livin mRNA level of cancer cell was remarkably decreased than before transfection and control group(p〈0.01) .It verified that the shRNA prepared can inhibit the express of Livin efficiently and the role of livin1 is more obvious,the inhibition rate of which was 66 percent. Conclusion:We constructed correctly the recombinant plasmid of Livin shRNA,which can inhibit the express of Livin efficiently .It also established the experiement foundation that explore the tumorous gene therapy of RNAi to Livin.
出处 《现代生物医学进展》 CAS 2009年第21期4048-4052,共5页 Progress in Modern Biomedicine
基金 国家"863"课题基金资助项目(No.2007AA021009)
关键词 LIVIN RNA干扰 质粒载体 Livin RNA interference plasmid vector
  • 相关文献

参考文献2

二级参考文献23

  • 1韦淑琴,王淑荣,呈丽,隋丽华.细胞外信号激酶在泰素引起的卵巢癌细胞凋亡中的作用(英文)[J].中国现代医学杂志,2004,14(19):1-5. 被引量:9
  • 2孙建国,廖荣霞,陈正堂,王志新,张青,胡义德,王东林.Livin异构体基因转染对肺腺癌A549细胞生长及放化疗敏感性的影响[J].中华结核和呼吸杂志,2005,28(12):836-840. 被引量:20
  • 3[1]Steller H. Mechanisms and genes of cellular suicide[J]. Science, 1995; 267(10): 1445-9
  • 4[2]Thompson CB. Apoptosis in the pathogenesis and treatment of disease[J]. Science, 1995; 267(10): 1456-62
  • 5[3]Lin JH, Deng G, Huang Q. KIAP, a novel member of the inhibitor of apoptosis protein family[J]. Biochemi Biophys Res Commun, 2000; 279(3): 820-31
  • 6[4]Vucic D, Henning R. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas[J]. Curr Biol, 2000; 10(21): 1359-66
  • 7[5]Kasof GM, Gomes BC. livin, a novel inhibitor of apoptosis protein family member[J]. J Biol Chem, 2001; 276(5): 3238-46
  • 8[6]Ashhab Y, Alian A, Panet A, Yeluda DB. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern[J]. FEBS Lett, 2001; 495(1,2): 56-60
  • 9[7]Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, et al. Caspase-mediated cleavage converts livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma[J]. Cancer Res, 2003; 63(19): 6340-9
  • 10[8]Gazzaniga P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I, et al. Expression and prognostic significance of livin, Survivin and other apoptosis-related genes in the progression of superficial bladder cancer[J]. Ann Oncol, 2003; 14(1): 85-90

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部